Basic fibroblast growth factor and epidermal growth factor reverse impaired ulcer healing of the rabbit oral mucosa

Journal of Oral Pathology and Medicine

Volumn 32, Issue 6, 2003, Pages 358-366

  Fujisawa, Kenji ^a   Miyamoto, Youji ^a   Nagayama, Masaru ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

bFGF; EGF; Impaired ulcer healing; Oral mucosa; Wound healing

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CISPLATIN; EPIDERMAL GROWTH FACTOR; MG 111; PEPLEOMYCIN; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; FEMALE; FIBROBLAST; KERATINOCYTE; MOUTH MUCOSA; MOUTH ULCER; NONHUMAN; RABBIT; SUBMANDIBULAR GLAND; ULCER HEALING;

ADMINISTRATION, TOPICAL; ANIMALS; CELL DIVISION; CISPLATIN; DISEASE MODELS, ANIMAL; DNA; EPIDERMAL GROWTH FACTOR; FEMALE; FIBROBLAST GROWTH FACTOR 2; GINGIVA; HUMANS; INJECTIONS, INTRAVENOUS; MOUTH MUCOSA; ORAL ULCER; PEPLOMYCIN; RABBITS; SUBMANDIBULAR GLAND; WOUND HEALING;

EID: 0038803924     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2003.t01-1-00111.x     Document Type: Article

References (30)

1. Sonis ST. Oral complication. In: Holland, JF et al., eds. Cancer Medicine, 4th edn. Philadelphia: William and Wilkins, 1977; 3255-65.
2. Clark RA. Cutaneous tissue repair. Basic biologic considerations. J Am Acad Dermatol 1985; 13: 701.
3. Shukla A, Dubey MP, Srivastava R, Srivastava BS. Differential expression of proteins during healing of cutaneous wounds in experimental normal and chronic models. Biochem Biophys Res Commun 1998; 244:434-9.
4. Frank S, Madlener M, Wemer S. Transforming growth factors β1, β2 and β3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem 1996; 271: 10188-93.
5. Mustoe TA, Pierce GF, Morishima C, Deuel TF. Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. J Clin Invest 1991; 87: 694-703.
6. Franklin JD, Lynch JB. Effects of topical applications of epidermal growth factor on wound healing. Plast Reconstr Surg 1979; 64: 766-70.
7. Breiung K, Andree C, Helo G, Slama J, Liu PY, Eriksson E. Growth factors in the repair of partial thickness porcine skin wounds. Plast Reconstr Surg 1997; 100: 657-64.
8. Kawaguchi H, Kurokawa T, Hanada K, et al. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 1994; 135: 774-81.
9. Uhl E, Barker JH, Bondar I, et al. Basic fibroblast growth factor accelerates wound healing in chronically ischaemic tissue. Br J Surg 1993; 80: 977-80.
10. Beck LS, Deguzman L, Lee WP, Xu Y, Siegel MW, Amento EP. One systemic administration of transforming growth factor β1 reverses age- or glucocorticoid-impaired wound healing. J Clin Invest 1993; 92: 2841-9.
11. Tsuboi R, Rifkin DB. Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice. J Exp Exp Med 1990; 172: 245-51.
12. Salomon GD, Kasid A, Bernstein E, Buresh C, Director E, Norton JA. Gene expression in normal and doxorubicin-impaired wounds: importance of transforming growth factor-beta. Surgery 1990; 108: 318-23.
13. Curtsinger LJ, Pietsch JD, Brown GL, et al. Reversal of adriamycin-impaired wound healing by transforming growth factor-beta. Surg Gynecol Obstet 1989; 168: 517-22.
14. Fujisawa K, Hayashi E, Kamata N, Nagayama M. Design of model for impaired healing of wound created on oral mucosa of rabbits. J Jpn Oral Muco Membr 1998; 4: 54-62 (in Japanese).
15. Staiano-Coico L, Krueger JG, Rubin JS, et al. Human keratinocyte growth factor effects in a porcine model of epidermal wound healing. J Exp Med 1993; 178: 865-78.
16. Hendriks T, Martens MFWC, Huyben CMLC, Wobbes T. Inhibition of basal and TGFβ-induced fibroblast collagen synthesis by anti-neoplastic agents. Implication for wound healing. Br J Cancer 1993; 67: 545-50.
17. Pierce GF, Mustoe TA, Lingelbach J, Masakowski VR, Gramates P, Deuel TF. Transforming growth factor β reverses the glucocorticoid-induced wound-healing deficit in rats: Possible regulation in macrophages by platelet-derived growth factor. Proc Natl Acad Sci USA 1989; 86: 2229-33.
18. Albertson S, Hummel RP, Breeden M, Greenhalgh DG. PDGF and FGF reverses the healing impairment in protein-malnourished diabetic mice. Surgery 1993; 114: 368-73.
19. Wu L, Pierce GF, Galiano RD, Mustoe TA. Keratinocyte growth factor induces granulation tissue in ischemic dermal wounds. Importance of epithelial-mesenchymal cell interactions. Arch Surg 1996; 131: 660-6.
20. Noguchi S, Ohba Y, Oka T. Effect of salivary epidermal growth factor on wound healing of tongue in mice. Am J Physiol 1991; 260: 620-5.
21. Bodner L, Dayan D, Rothchild D, Hammel I. Extraction wound healing in desalivated rats. J Oral Pathol Med 1991; 20: 176-8.
22. Bodner L, Dayan D, Pinto Y, Hammel I. Characteristics of palatal wound healing in desalivated rats. Arch Oral Biol 1993; 38: 17-21.
23. Ohshima M, Sato M, Ishikawa M, Maeno M, Otsuka K. Physiologic levels of epidermal growth factor in saliva stimulate cell migration of an oral epithelial cell line, HO-1-N-1. Eur J Oral Sci 2002; 110: 130-6.
24. Nagy A, Nagashima H, Cha S, et al. Reduced oral wound healing in the NOD mouse model for type 1 autoimmune diabetes and its reversal by epidermal growth factor supplementation. Diabetes 2001; 50: 2100-4.
25. Oxford GE, Tayari L, Barfoot MD, Peck AB, Tanaka Y, Humphreys-Beher MG. Salivary EGF levels reduced in diabetic patient. J Diabetes Complications 2000; 14: 140-5.
26. Graves LM, Bornfeldt KE, Krebes EG. Historical perspectives and new insights involving the MAP kinase cascades. Adv Second Messenger Phosphoprotein Res 1997; 31: 49-61.
27. Lee Y-S, Yuspa SH, Dlugosz AA. Differentiation of culture human epidermal keratinocytes at high cell densities is mediated by endogenous activation of protein kinase C signaling pathway. J Invest Dermatol 1998; 111: 762-6.
28. van Setten GB. Basic fibroblast growth factor in human saliva. detection and physiological implications. Laryngoscope 1995; 105: 610-2.
29. Ishizaki H, Westermark A, van Setten G, Pyykko I. Basic fibroblast growth factor (bFGF) in saliva. Physiological and clinical implications. Acta Otolaryngol 2000; 543 (Suppl): 193-5.
30. Kagami H, Hiramatsu Y, Hishida S, et al. Salivary growth factors in health and disease. Adv Dent Res 2000; 14: 99-102.